Pfizer lies behind Mylan’s issues with Epipen

Pfizer lies behind Mylan’s issues with Epipen

Source: 
GoinPharma
snippet: 

Mylan’s EpiPen is hard to be found in Canada and the UK and in severe shortage in the US. The problem is due to Pfizer, acting as a supplier to Mylan, which is experiencing issues in manufacturing enough product units in the St. Louis (Missouri) plant, operated by the  Meridian Medical Technologies Inc unit (100% Pfizer).